top of page

NEWS
Mar 16, 2023
Amgen cites inflation, pressure on drug prices in 450-person layoff
Amgen is laying off about 450 workers, the company told Endpoints News, just two months after letting go 300 staffers...
Jan 5, 2023
Terns Pharmaceuticals to Highlight 2023 Priorities and Clinical Milestones
FOSTER CITY, Calif., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a ...
Nov 20, 2022
Bristol Myers Squibb warns US price reforms will dent drug development
Bristol Myers Squibb says it expects to cancel some drug development programmes due to US government drug pricing rules that are due to...
Oct 31, 2022
Eli Lilly blames Biden's IRA for cancer drug discontinuation as the new pharma playbook takes shape
Eli Lilly laid blame Tuesday afternoon on President Joe Biden’s Inflation Reduction Act as the reason it scrapped a $40 million cancer...
Oct 26, 2022
As Amvuttra makes inroads in ATTR, Alnylam scraps heart disease trial interim analysis
Readout for newly FDA-approved Amvuttra in a rare heart disease is on many Alnylam investors’ mind. But the company figures patience is a...
bottom of page